Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  The American journal of geriatric psychiatry

• Publication date

  2006-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.JGP.0000196628.12010.35PMID 16905684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease

  2004cited by this paper
• Psychosis of Alzheimer disease: validity of the construct and response to risperidone.

  2003cited by this paper
• P.2.102 Aripiprazole treatment for psychosis in patients with Alzheimer's disease

  2003cited by this paper
• A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

  2003cited by this paper
• Haloperidol for agitation in dementia.

  2002cited by this paper
• Use of quetiapine in elderly patients.

  2002cited by this paper
• Sodium valproate in the treatment of aggressive behavior in patients with dementia—a randomized placebo controlled clinical trial

  2002cited by this paper
• Placebo-controlled study of divalproex sodium for agitation in dementia.

  2001cited by this paper
• Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study

  2001cited by this paper
• Treatment of agitation in AD

  2000cited by this paper
• The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement.

  2000cited by this paper
• Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome.

  2000cited by this paper
• Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.

  2000cited by this paper
• Long-Term use of quetiapine in elderly patients with psychotic disorders.

  2000cited by this paper
• Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.

  1999cited by this paper
• A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia

  1999cited by this paper
• A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.

  1998cited by this paper
• Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease.

  1996cited by this paper
• The Neuropsychiatric Inventory

  1994cited by this paper
• A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia

  1990cited by this paper
• A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease.

  1989cited by this paper
• Psychometric assessment of the Multidimensional Observation Scale for Elderly Subjects (MOSES).

  1988cited by this paper
• Standardization and validation of the Multidimensional Observation Scale for Elderly Subjects (MOSES).

  1987cited by this paper
• The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit.

  1984cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: II. Representative profile patterns.

  1984cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

  1970cited by this paper
• Assessment of older people: self-maintaining and instrumental activities of daily living.

  1969cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper

• Current and Emerging Therapeutic Approaches for Vascular Cognitive Impairment and Dementia.

  2026cites this paper
• Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future.

  2026cites this paper
• Major adverse cardiac events with haloperidol: A meta-analysis

  2025cites this paper
• Comparative Efficacy and Tolerability of Multiple Antipsychotics Across Varying Doses for Neuropsychiatric Symptoms of Dementia Including Alzheimer's Disease: A Dose–Response Model‐Based Network Meta‐Analysis

  2025cites this paper
• Clinical Practice Guidelines for Dementia: Recommendations for the Pharmacological Treatment of Behavioral and Psychological Symptoms

  2025cites this paper
• A Trajectory of Long-Term Antipsychotic Medication Dosage in Inpatients with Severe Behavioral and Psychological Symptoms of Dementia: A Retrospective Study

  2024cites this paper
• The treatment of behavioural and psychological symptoms in dementia: pragmatic recommendations

  2024cites this paper
• Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia Connection and Co-morbid Risks

  2024cites this paper
• Efficacy of selective serotonin reuptake inhibitors-related antidepressants in Alzheimer’s disease: a meta-analysis

  2024influential citation
• Efficacy, acceptability and tolerability of second-generation antipsychotics for behavioural and psychological symptoms of dementia: a systematic review and network meta-analysis

  2024cites this paper
• Challenges and proposed solutions to conducting Alzheimer’s disease psychosis trials

  2024cites this paper
• Quetiapine Oral Solution in Alzheimer’s Disease: Efficacy and Dosage Insights from a Real-World Retrospective Study

  2023cites this paper
• Clinical Trial Studies of Antipsychotics during Symptomatic Presentations of Agitation and/or Psychosis in Alzheimer’s Dementia: A Systematic Review

  2023cites this paper
• Emotional and Neuropsychiatric Disorders Associated with Alzheimer’s Disease

  2022cites this paper
• Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis

  2022cites this paper
• Comparative Efficacy, Safety, Tolerability, and Effectiveness of Antipsychotics in The Treatment of Dementia-Related Psychosis (DRP): A Systematic Literature Review

  2021influential citation
• Efficacy and safety of pharmacotherapy for Alzheimer’s disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials

  2021cites this paper
• Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.

  2021cites this paper
• Urinary side effects of psychotropic drugs: A systematic review and metanalysis

  2021cites this paper
• Large Sample Size Fallacy in Trials About Antipsychotics for Neuropsychiatric Symptoms in Dementia

  2020cites this paper
• Nicotinic acetylcholine receptors: Diversity and physiological importance for neurodegenerative disorders and development of organophosphate antidotes

  2020cites this paper
• Pharmacological Management of Neuropsychiatric Symptoms of Dementia

  2020cites this paper
• Pharmacological Agents to Treat Severe Neuropsychiatric Symptoms in Major Neurocognitive Disorders

  2020cites this paper
• A case of reversible aphasia-type speech disorders after treatment with quetiapine.

  2020cites this paper
• Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD).

  2020cites this paper
• Cost-effectiveness of atypical antipsychotics for the treatment of dementia in Thailand

  2019cites this paper
• Run‐in periods and clinical outcomes of antipsychotics in dementia: A meta‐epidemiological study of placebo‐controlled trials

  2019cites this paper
• Psychotropic drug use in community-dwelling people with young-onset dementia: two-year course and determinants

  2019cites this paper
• Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia

  2019cites this paper
• Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA

  2019cites this paper
• Subjective Versus Objective Outcomes of Antipsychotics for the Treatment of Neuropsychiatric Symptoms Associated with Dementia

  2019cites this paper
• Baseline imbalances and clinical outcomes of atypical antipsychotics in dementia: A meta‐epidemiological study of randomized trials

  2018influential citation
• The use of antipsychotics is associated with lower mortality in patients with Alzheimer’s disease: A nationwide population-based nested case-control study in Taiwan

  2018cites this paper
• Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study.

  2018cites this paper
• Schizophrenia and Other Psychotic Disorders ( J Csernansky , Section Editor ) Antipsychotic Pharmacotherapy for Neuropsychiatric Symptoms of Dementia

  2018cites this paper
• Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta‐analysis

  2018cites this paper
• Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study.

  2018cites this paper
• Interventions for preventing falls in older people in care facilities and hospitals

  2018cites this paper
• Management of Neuropsychiatric Symptoms in Neurocognitive Disorders.

  2017cites this paper
• Association between antipsychotics and adverse outcomes in dementia

  2017cites this paper
• Psychosis and dementia: risk factor, prodrome, or cause?

  2017cites this paper
• Best practice in the management of behavioural and psychological symptoms of dementia

  2017cites this paper
• Comparative Utility of Atypical Antipsychotics for the Treatment of Psychosis in Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis.

  2017cites this paper
• Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia.

  2017cites this paper
• Do antipsychotics lead to cognitive impairment in dementia? A meta-analysis of randomised placebo-controlled trials

  2017cites this paper
• Benefits and harms of atypical antipsychotics for agitation in adults with dementia.

  2017cites this paper
• A Single-Dose Crossover Pharmacokinetic Comparison Study of Oral, Rectal and Topical Quetiapine in Healthy Adults

  2016cites this paper
• Trends, correlates, and disease patterns of antipsychotic use among elderly persons in Taiwan

  2016cites this paper
• Psychosis in Alzheimer’s Disease: a Review of Recent Research Findings

  2016cites this paper
• Drug Therapy for Behavioral and Psychological Symptoms of Dementia

  2016cites this paper
• Arterial Stiffness in Patients Taking Second-generation Antipsychotics

  2016cites this paper
• Impact of current antipsychotic medications on comparative mortality and adverse events in people with Parkinson’s disease psychosis (PDP)

  2016cites this paper
• Quetiapine safety in older adults: a systematic literature review

  2016influential citation
• TRABAJO DE FIN DE GRADO

  2016cites this paper
• Retraction Note: Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis

  2015cites this paper
• Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.

  2015cites this paper
• Association of quetiapine with ischemic brain stem stroke: a case report and discussion

  2015cites this paper
• Efficacy and cost of atypical antipsychotics in treatment and management of dementia

  2015cites this paper
• Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review)

  2015cites this paper
• Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis

  2015cites this paper
• A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents.

  2015cites this paper
• The Mortality Risk of Conventional Antipsychotics in Elderly Patients: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials.

  2015cites this paper
• Efficacy of Atypical Antipsychotics to Treat Behavioral and Psychological Symptoms of Dementia in Nursing Home Residents: A Systematic Review of the Evidence from Randomized Controlled Trials

  2015cites this paper
• Predictors of home discharge among patients hospitalized for behavioural and psychological symptoms of dementia

  2015cites this paper
• Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action

  2014cites this paper
• Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions

  2014influential citation
• Pharmacological management of behavioral symptoms associated with dementia.

  2014cites this paper
• Atypical Antipsychotic-Induced Metabolic Disturbances in the Elderly

  2014cites this paper
• Role of antipsychotics for treating behavioral and psychological symptoms of dementia

  2014cites this paper
• Cognition and Neuropsychiatric Symptoms

  2014cites this paper
• The Efficacy and Safety of Atypical Antipsychotics for the Treatment of Dementia: A Meta-Analysis of Randomized Placebo-Controlled Trials

  2014cites this paper
• Éthique des soins aux personnes âgées : la capacité à consentir et traitement involontaire

  2014cites this paper
• A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.

  2014cites this paper
• Efficacy of quetiapine off-label uses: data synthesis.

  2013influential citation
• Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study

  2013cites this paper
• The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease.

  2013cites this paper
• Tolerability of extended‐release quetiapine fumarate compared with immediate‐release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double‐blind, parallel‐group study

  2012influential citation
• Addressing the Controversial Use of Antipsychotic Drugs for Behavioral and Psychological Symptoms of Dementia

  2012cites this paper
• Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review

  2012cites this paper
• Interventions for preventing falls in older people in care facilities and hospitals.

  2012cites this paper
• Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services

  2012cites this paper
• Hallucinations in Neurodegenerative Diseases

  2012cites this paper
• Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.

  2012cites this paper
• Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults

  2011cites this paper
• Quetiapine for the treatment of behavioural and psychological symptoms of dementia (BPSD): a meta-analysis of randomised placebo-controlled trials.

  2011cites this paper
• Psychotropic Drugs in the Elderly Treatment Considerations Sept 2011

  2011cites this paper
• Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.

  2011cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Alzheimer's disease and other dementias

  2011cites this paper
• 1. Alzheimer's Disease

  2011cites this paper
• A Tipping Point in Drug Dosing in Late-Life Schizophrenia

  2011influential citation
• Long-Term Management of Dementia

  2011influential citation
• Representation of people with intellectual disabilities in randomised controlled trials on antipsychotic treatment for behavioural problems.

  2011cites this paper
• Cerebrovascular Accidents in Elderly People Treated with Antipsychotic Drugs

  2010cites this paper
• The Link Between Psychosis and Aggression in Persons with Dementia: A Systematic Review

  2010cites this paper
• Behavioural Management in Alzheimer's Disease - Pharmacology

  2010cites this paper
• The Elderly Safety Imperative and Antipsychotic Usage

  2010cites this paper
• Agitation in Patients with Dementia - Challenges in Diagnosis and Treatment

  2010cites this paper
• Interventions for preventing falls in older people in nursing care facilities and hospitals.

  2010cites this paper
• Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials

  2010cites this paper
• Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report

  2010cites this paper